Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: OTJR (Thorofare N J). 2018 Mar 7;39(1):5–13. doi: 10.1177/1539449218762728

Table 2.

Feasibility, acceptability, and efficacy data to be collected.

Factor/Outcome Information Gathered Data Source/Measure
Feasibility & Acceptability
Process Recruitment % (of # approached) recruited over 1 mo; % recruited from various sources Recruitment logs; Screening forms
Reach Representativeness of individuals willing and eligible to participate Recruitment logs; Screening forms; Antelope Valley census data; AVCC patient statistics
Retention % completing post-intervention assessment Testing logs
Adherence 16-wk session-by-session attendance Intervener attendance logs
Fidelity Proportion of applicable core intervention elements incorporated; Perceived use of core intervention elements Fidelity index; Stakeholder interviews; Intervener session notes
Implementation barriers/facilitators Perceived implementation barriers/facilitators Participant focus groups; Participant interviews; Stakeholder interviews
Implementation alterations Changes made to the intervention during implementation Intervener session notes; Stakeholder interviews; Study team daily operations communications
Satisfaction Participant and stakeholder experiences Participant interview and survey; Participant focus groups; Stakeholder interviews
Adoption Willingness by staff and primary care provider to initiate the program Stakeholder interviews
Resources Equipment reliability Equipment availability and functionality Stakeholder interviews; Study team daily operations communications; Staff time logs; Expenditures log
Personnel Sufficiency of personnel to carry out all aspects of the study
Space Sufficiency of space to carry out study
Time Sufficiency of time to carry out study
Budget Study expenditures
Management Data Database set-up; Data accessibility, accuracy and maintenance; EMR availability REDCap; Stakeholder interviews; Study team daily operations communications; EMRs
Administration Research team’s administrative capacity to manage the study; Compliance with human subjects protection protocol Stakeholder interviews; Study team daily operations communications; Intervener notes; Adverse event logs
Preliminary Efficacy
Scientific Assessment Safety # and type of adverse events documented Adverse event logs
Patient-identified symptom profile (PISP) Change in symptom impact/severity MYMOP2
Food frequency Change in dietary intake Block FFQ
Physical activity Change in physical activity level IPAQ
Social functioning satisfaction Change in satisfaction with social participation PROMIS Short Form 7a: Satisfaction with Social Roles; Satisfaction with Participation in Discretionary Social Activities
Sleep quality Change in quality of sleep PSQI
Stress Change in perceived stress level Single Item Stress Index
Hemoglobin A1c Change in hemoglobin A1c Non-fasting hemoglobin A1c test via finger prick
Blood pressure Change in systolic/diastolic blood pressure Digital blood pressure reading
BMI (kg/m) Change in BMI Digital scale and stadiometer reading
Waist/hip circumference Change in waist and hip circumference Tape measure
Coronary heart disease risk Change in coronary heart disease risk Framingham Risk Score LDL Points Total
Diabetes risk Change in risk for diabetes EPIC Diabetes Risk Score
Patient activation Activation level (baseline not available) PAM 13

AVCC= Antelope Valley Community Clinic; Block FFQ= Block 2005 Food Frequency Questionnaire Spanish Version; BMI= body mass index; EPIC= European Prospective Investigation into Cancer and Nutrition; EMR= electronic medical record; IPAQ = International Physical Activity Questionnaire; MYMOP2= Measure Yourself Medical Outcome Profile; PAM 13= Patient Activation Measure 13-item short form; PROMIS= Patient Reported Outcomes Measurement Information System; PSQI= Pittsburgh Sleep Quality Index; SES= socioeconomic status; SRT= signed rank test.